Remdesivir Approved in US for Use in Hospitalized COVID-19 Patients
The US Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease, Reuters reports.
Gilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October.
Remdesivir, previously granted emergency use authorization by the FDA for COVID-19, was one of the drugs used to treat US President Donald Trump’s recent coronavirus infection.
Read More at israelnationalnews
